+1 (234)-456 657
123 Main, Main Town NJ 00000
6000 Executive Blvd. # 101 , North Bethesda MD 28052
Office Hours: 8am – 6pm
Trusted for safety & effectiveness
FDA Approved
Many experience results in as little as 2 weeks
Now available at Bright Horizons Psychiatry
Trusted By
Trusted By
1. No Cost Consultation
2. Personalized Treatment Plan
3. Start Treatment
SPRAVATO® Therapy is highly effective in treating depression.
You can now get treatment free of anti-depressant medication.
Low cost solution compared to other treatments
Most patients experience relief within a few hours to a few days.
Infusion Therapy is highly effective in treating depression.
You can now get treatment free of anti-depressant medication.
Low cost solution compared to other treatments
Most patients experience relief within a few hours.
FDA Approved
Scientifically proven
Covered by major insurances
Relief within hours
Bright Horizons Psychiatry in North Bethesda, Maryland, provides comprehensive psychiatric care for adults ages 18 and over who suffer from mood disorders.
Experienced psychiatrist Amir Etesam, MD, and his team correctly diagnose a range of mental health conditions, from depression and anxiety to obsessive-compulsive disorder (OCD), and provide second opinions for patients with complex, treatment-resistant conditions.
covered By
covered By
Yes. You have to be on an antidepressant medication to receive nasal SPRAVATO® spray.
SPRAVATO® nasal spray is FDA approved for two indications:
Treatment-resistant depression (patients who have tried previous oral antidepressants with unsatisfactory results)
Major depressive disorder with acute harmful behaviors
You shouldn't take SPRAVATO® nasal spray if you have:
Uncontrolled hypertension
History of strokes or brain bleeds
Abnormal blood vessels at risk of bleeding, such as aneurysms or ateriorvenous malformations (AVMs)
Sensitivity to SPRAVATO®
During your free consultation, our team will help you decide if keta-based depression treatment is right for you.
No. SPRAVATO® nasal spray is FDA approved for two indications:
Treatment-resistant depression (patients who have tried previous oral antidepressants with unsatisfactory results)
Major depressive disorder with acute harmful behaviors
Yes. SPRAVATO® nasal spray is FDA approved for two indications:
Treatment-resistant depression (patients who have tried previous oral antidepressants with unsatisfactory results)
Major depressive disorder with acute harmful behaviors